Timing of treatment for nonneutropenic patients colonized with Candida (Q41324862)

29 September 2017

1 reference

title

Timing of treatment for nonneutropenic patients colonized with Candida (English)

1 reference

29 September 2017

Solomkin JS

1

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

The American Journal of Surgery

29 September 2017

published in

1 reference

29 September 2017

volume

172

1 reference

29 September 2017

issue

6A

1 reference

29 September 2017

page(s)

44S-48S

1 reference

Major trends in the microbial etiology of nosocomial infection.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Candida infections in surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Hospital-acquired fungemia. Its natural course and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Nosocomial fungemia in a large community teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Should all patients with candidemia be treated with antifungal agents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Scanning electron microscopy of oral lesions in chronic mucocutaneous candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Candida Overgrowth in Gastric Juice of Peptic Ulcer Subjects on Short- and Long-Term Treatment with H<sub>2</sub>-Receptor Antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Risk factors for hospital-acquired candidemia. A matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

The potentially lethal problem of cardiac candidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Elimination of amphotericin B in impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Adhesion of Candida species to epithelial surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Candida proteinases and candidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Oral azole drugs as systemic antifungal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

In vitro models for studying toxicity of antifungal agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Risk factors for nosocomial candidemia: a case-control study in adults without leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Candida colonization and subsequent infections in critically ill surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Development of resistance in candida isolates from patients receiving prolonged antifungal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

7 January 2021

Treatment of funguria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Urinary tract infections due to Candida albicans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Fluconazole in the Treatment of Hepatosplenic Candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Yeasts in blood cultures: impact of early therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Indications for therapy for fungemia in postoperative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Prospective study of Candida endophthalmitis in hospitalized patients with candidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Incidence of polyene-resistant yeasts recovered from clinical specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

Venous catheter-associated candidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

7 January 2021

Adherence of Candida species to host tissues and plastic surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

7 January 2021

Cell extracts of Candida albicans block adherence of the organisms to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

7 January 2021

Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900350-9

7 January 2021

10.1016/S0002-9610(96)00350-9

Identifiers

DOI

1 reference

29 September 2017

1 reference